-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Exploring CLL and MCL: Disease Overview, Latest Treatment Options and Unmet Needs

Sponsor: AstraZeneca
Program: Industry Theaters
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality), Treatment Considerations, Biological therapies, Non-Biological therapies
Sunday, December 8, 2024: 11:30 AM-12:30 PM
Room 4 (San Diego Convention Center)
Speaker:
Carol Moreno, AstraZeneca
Disclosures:
No relevant conflicts of interest to declare.

This presentation is intended for U.S. based registered meeting attendees

For in-person participants only
See more of: Industry Theaters
<< Previous Session | Next Session >>